Lamond Capital Partners’s Amgen AMGN Stock Holding History

Lamond Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-75,000	Closed	-$12.2M	–	2
2015 Q4	$12.2M	Sell	75,000 -25,000	-25%	-$3.93M	18.2%	4
2015 Q3	$13.8M	Buy	100,000 +3,370	+3%	+$531K	10.35%	5
2015 Q2	$14.8M	Buy	96,630 +49,040	+103%	+$7.86M	15.06%	2
2015 Q1	$7.61M	Buy	+47,590	New	+$7.5M	8.31%	6
2014 Q4	–	Sell	-70,000	Closed	-$9.83M	–	16
2014 Q3	$9.83M	Buy	+70,000	New	+$9.14M	10.92%	4

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Lamond Capital Partners's AMGN Position: Q1 2016 in Review

Lamond Capital Partners sold out of Amgen (AMGN) in Q1 2016, closing a stake of 75,000 shares — an estimated $12.2M sold.

Lamond Capital Partners first reported a position in AMGN in Q3 2014 and held it in 5 quarters. The position peaked at $14.8M in Q2 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

Lamond Capital Partners reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
Lamond Capital Partners sold 75,000 Amgen shares in Q1 2016, an estimated $12.2M.
Lamond Capital Partners first reported a position in Amgen in Q3 2014 and held it in 5 quarters.
Lamond Capital Partners's Amgen position peaked at $14.8M in Q2 2015.
1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Lamond Capital Partners's 13F filing for Q1 2016, filed 5 May 2016.